Calleja, José Luis
Aguilera, Antonio
Buti, Maria
Crespo, Javier http://orcid.org/0000-0001-8248-0172
García, Federico
Jorquera, Francisco
Morano, Luis Enrique http://orcid.org/0000-0002-0560-3260
Macias, Juan
Lazarus, Jeffrey V. http://orcid.org/0000-0001-9618-2299
Article History
First Online: 23 June 2022
Competing interests
: J.L.C. reports grants to his institution from Gilead Sciences and personal fees from AbbVie, Gilead Sciences, MSD and Intercept, outside of the submitted work. A.A. reports personal fees from AbbVie, Gilead Sciences, MSD, Roche and Abbott, outside of the submitted work. M.B. reports advisory fees from Gilead Sciences, AbbVie, GlaxoSmithKline and Assembly Biosciences, and speaker fees from Gilead Sciences and AbbVie, outside of the submitted work. J.C. reports consulting and personal fees from Gilead Sciences, AbbVie, MSD, Shionogi, Intercept Pharmaceuticals, Janssen Pharmaceuticals Inc., Celgene and Alexion, outside of the submitted work. F.G. reports grants to his institution from AbbVie, Gilead Sciences, MSD and ViiV, and personal fees from AbbVie, Gilead Sciences, Janssen, MSD, ViiV, Roche, Qiagen and Menarini, outside of the submitted work. L.E.M. reports personal fees from AbbVie, Gilead Sciences, Janssen, MSD and ViiV, outside of the submitted work. J.M. reports grants to his institution from Gilead Sciences, MSD, Janssen and ViiV, and personal fees from Gilead Sciences, MSD and ViiV, outside of the submitted work. J.V.L. reports grants to his institution from AbbVie, Gilead Sciences and MSD, and personal fees from AbbVie, CEPHEID, Gilead Sciences, GSK, Genfit, Intercept, Janssen, MSD and ViiV, outside of the submitted work. F.J. declares no competing interests.
Free to read: This content has been made available to all.